澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: iron oxide red; purified talc; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; magnesium stearate; macrogol 6000 - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.8 mg) - tablet, film coated - excipient ingredients: iron oxide yellow; macrogol 6000; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; pregelatinised maize starch; purified talc - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: purified talc; macrogol 6000; lactose monohydrate; hypromellose; magnesium stearate; pregelatinised maize starch; iron oxide red; titanium dioxide - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - alendronate sodium, quantity: 91.35 mg (equivalent: alendronic acid, qty 70 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; macrogol 8000; carrageenan; magnesium stearate - treatment of osteoporosis, including glucocorticoid induced osteoporosis. osteoporosis must be confirmed by the finding of low bone mass of at least two standard deviations below the gender specific mean for young adults, or by the presence of osteoporotic fracture.

沙特阿拉伯 - 英文 - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

world medicine İlaç san. ve tic. a.Ş., turkey - donepezil hydrochloride - film-coated tablet - 5 mg

沙特阿拉伯 - 英文 - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

world medicine İlaç san. ve tic. a.Ş., turkey - donepezil hydrochloride - film-coated tablet - 5 mg

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: purified water; lactose monohydrate; magnesium stearate; hyprolose; hypromellose; microcrystalline cellulose; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; lactose monohydrate; purified water; microcrystalline cellulose; hyprolose; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; hypromellose; hyprolose; magnesium stearate; purified water; titanium dioxide; iron oxide yellow; macrogol 4000 - indicated for the treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; purified talc; microcrystalline cellulose; titanium dioxide; hyprolose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; macrogol 6000 - indicated for the treatment of hypertension. indicated for delaying the progression of renal disease in hypertensive type ii diabetics with persistent micro-albuminuria (greater than or equal to 30mg per 24 hours) or urinary protein in excess of 900mg per 24 hours.